Share this article on:

2.5 CE Test Hours: Early Localized Prostate Cancer

Contrada, Emily

AJN The American Journal of Nursing: March 2015 - Volume 115 - Issue 3 - p 45,46
doi: 10.1097/01.NAJ.0000461821.40440.83
Feature Articles
Back to Top | Article Outline

Test Instructions

  • To take the test online, go to our secure Web site at
  • To use the form provided in this issue, record your answers in the test answer section of the CE enrollment form below. Each question has only one correct answer. You may make copies of the form.
  • Complete the registration information and course evaluation. Mail the completed enrollment form and registration fee to: Lippincott Williams and Wilkins, CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. You will receive your certificate in four to six weeks. For faster service, include a fax number and we will fax your certificate within two business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no minimum passing grade.
  • Registration deadline is March 31, 2017.
Back to Top | Article Outline

Discounts and Customer Service

  • Send in together two or more tests from any nursing journal published by Lippincott, Williams and Wilkins (LWW), and deduct $0.95 from the price of each test.
  • We also offer CE accounts for hospitals and other health care facilities online at Call 1-800-787-8985 for details.
Back to Top | Article Outline

Provider Accreditation

LWW, publisher of AJN, will award the number of contact hours indicated for each continuing nursing education activity. LWW is accredited as a provider of continuing nursing education by the Commission on Accreditation of the American Nurses Credentialing Center (ANCC).

These activities are also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for the number of contact hours indicated. LWW is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.



The ANCC's accreditation status of the LWW Department of Continuing Education refers to its continuing nursing educational activities only and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Back to Top | Article Outline


To provide information about the multiple options available for men with newly diagnosed, localized, low-risk prostate cancer while also explaining how nurses can help men and their partners make treatment decisions that are appropriate for their particular circumstances.

Back to Top | Article Outline


After reading this article and taking this test, you will be able to

  • select treatment options for newly diagnosed, localized, low-risk prostate cancer.
  • recognize the information needed by patients and partners to enable them to make appropriate treatment decisions.
  1. 1.In 2011, about how many men in the United States had at some point been diagnosed with prostate cancer?
    1. just under 1.7 million
    2. almost 2.8 million
    3. nearly 3.6 million
  2. According to the American Cancer Society, of the 233,000 men in the United States who are diagnosed with prostate cancer each year, what percentage is 65 years old or older?
    1. 40%
    2. 50%
    3. 60%
  3. Prostate cancer is diagnosed on the basis of which of the following?
    1. 12-core biopsy
    2. digital rectal examination
    3. prostate-specific antigen (PSA) test
  4. Guidelines from the American Urological Association (AUA) recommend against PSA screening in men who
    1. are under the age of 60.
    2. are over the age of 40.
    3. are between the ages of 40 and 54 and are not at elevated risk.
  5. The AUA recommends PSA screening in men at higher risk, such as those who are
    1. white.
    2. black.
    3. Asian.
  6. In a study of Medicare participants who underwent prostate biopsy and required hospitalization within 30 days of biopsy, the most common cause was
    1. pain.
    2. hematuria.
    3. infection.
  7. Gleason scores of 2 to 5 are reported as
    1. Gleason 5 disease.
    2. Gleason 6 disease.
    3. Gleason 7 disease.
  8. Protocols for active surveillance involve PSA testing at least every
    1. 3 months.
    2. 6 months.
    3. 9 months.
  9. Of the men starting active surveillance, about what percentage will go on to have treatment within 2 to 3 years of diagnosis?
    1. 25%
    2. 37%
    3. 46%
  10. After radical prostatectomy, what percentage of men die of the disease within 15 years of surgery?
    1. fewer than 10%
    2. nearly 15%
    3. about 50%
  11. After radical prostatectomy, 5% to 48% of men develop
    1. penile shrinkage.
    2. loss of erectile function.
    3. stress urinary incontinence.
  12. After radical prostatectomy, men lose the ability to
    1. ejaculate.
    2. achieve erection.
    3. experience orgasm.
  13. Which of the following drugs may mitigate the loss of penile length?
    1. duloxetine
    2. sildenafil
    3. oxybutynin
  14. A widely used form of penile rehabilitation is nightly use of a low-dose phosphodiesterase type 5 inhibitor, beginning shortly after surgery and continuing for how long?
    1. 6 months
    2. 12 months
    3. 24 months
  15. Which of the following techniques provides radiation treatment with radioactive seeds placed directly into the prostate gland?
    1. brachytherapy
    2. a robotic system
    3. external beam
  16. Adverse effects of radiation therapy for prostate cancer include
    1. hematuria.
    2. rectal pain.
    3. anal leakage.
  17. The 5-year survival rate after cryotherapy for prostate cancer is
    1. 54%.
    2. 65%.
    3. 77%.
  18. Compared with heterosexual men, gay men undergoing treatment for prostate cancer were significantly more distressed by
    1. the loss of ejaculation.
    2. rectal pain and bleeding.
    3. stress urinary incontinence.
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.